Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)
China
· Delayed Price · Currency is CNY 8.82
+0.07 (0.80%)
Jun 6, 2025, 2:45 PM CST
SHE:002728 Revenue
Teyi Pharmaceutical Group Co.,Ltd had revenue of 295.13M CNY in the quarter ending March 31, 2025, with 79.29% growth. This brings the company's revenue in the last twelve months to 818.31M, down -11.79% year-over-year. In the year 2024, Teyi Pharmaceutical Group Co.,Ltd had annual revenue of 687.79M, down -35.55%.
Revenue (ttm)
818.31M
Revenue Growth
-11.79%
P/S Ratio
5.38
Revenue / Employee
610.22K
Employees
1,341
Market Cap
4.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 687.79M | -379.43M | -35.55% |
| Dec 31, 2023 | 1.07B | 180.64M | 20.38% |
| Dec 31, 2022 | 886.57M | 128.41M | 16.94% |
| Jan 1, 2022 | 758.16M | 125.47M | 19.83% |
| Dec 31, 2020 | 632.70M | -288.43M | -31.31% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |